1) Financial Performance Highlights
- Revenue growth of 9.7% at constant currency and 5.7% at current exchange rates for H1 2026. - Adjusted operating profit increased by 15%, with cash generation exceeding €1 billion. - Q2 revenue growth was 8.7% at constant currency, with North America, EMEA, and Latin America showing high-single-digit growth, while Asia Pacific achieved double-digit growth. - Gross profit margin improved by 10 basis points, with operating profit up 80 basis points at constant currency.

2) Strategic Developments and Innovations
- EssilorLuxottica is advancing into the oculomics field, integrating eye health with broader healthcare services, exemplified by the opening of a vision and eye health surgery center in Philadelphia. - A partnership with Applied Materials aims to develop intelligent optical systems for AI and AR wearables, enhancing their product offerings in smart eyewear. - Continued investment in R&D, particularly in myopia management and the launch of new products like Stellest in Japan and the U.S., which is now available in 11,000 doors.

3) Market Dynamics and Product Performance
- Strong performance in the eyewear segment, particularly with Ray-Ban and luxury brands like Miu Miu and Chanel. - The wearables category is experiencing exponential growth, with smart glasses sales nearly doubling in Q2. - The company is focusing on expanding its direct-to-consumer channels, with LensCrafters achieving high-single-digit comp sales for the 14th consecutive quarter.

4) Challenges and Operational Insights
- Some slowdown observed in large account sales in North America, but overall performance remains strong over a six-month period. - The company is managing inflationary pressures effectively, with no significant concerns regarding operating expenses for H2 2026. - Tariff refunds contributed positively to gross margins, with expectations for continued benefits in the second half of the year.

5) Guidance and Future Outlook
- EssilorLuxottica remains optimistic about H2 2026, supported by a strong innovation pipeline and continued productivity improvements. - The company anticipates a demanding comparison base but expects growth driven by new product launches and enhanced distribution capabilities. - Further details on the impact of tariffs and cost dynamics are expected in future communications.

Bottom line: EssilorLuxottica is positioned for robust growth, leveraging its strategic advancements in oculomics and wearables, while maintaining strong financial performance and operational efficiency. The outlook for H2 2026 remains positive, supported by innovative product launches and expanding market presence.